Pfizer has 519 injectable products listed in the report, with 249, or 48 percent, labeled as available. The report says the supply of 152 are depleted and 118 are in limited supply.
The document does not include a reason for why an injectable is in shortage or out or stock.
In July, a tornado struck a Pfizer manufacturing plant and warehouse in Rocky Mount, N.C., which supplied 8 percent of the nation’s injectable drugs used in hospitals. The damage was mainly on the site’s storage side, but the company placed order limits on a dozen drugs as 65 solutions face worsened or new supply issues.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
